Metri Bio's CEO, Ashley Abel, selected for Forbes 30 Under 30

Metri Bio Raises $5M Pre-Seed to Develop Endometriosis Therapeutics

News

Metri Bio CEO Ashley Abel co-authors review in Nature Biomedical Engineering

September 25, 2026

Metri Bio CEO Ashley Abel on why endometriosis research needs to start with the biology

September 25, 2026

Michele Keough Joins Metri Bio as Chief Operating Officer

July 22, 2026

Metri Bio Expands Its Voice Across Women’s Health and Biotechnology

June 30, 2026

Dr. Michael Rogers Joins Metri Bio’s Scientific Advisory Board

June 1, 2026

Metri Bio Featured in EndoRISE’s “1 in 10” Endometriosis Story

March 31, 2026

Pillar VC Shares Why It Invested in Metri Bio

March 26, 2026

Metri Bio CEO Ashley Abel Selected for the 2026 Termeer Fellowship

March 24, 2026

HealthyWomen Profiles Ashley Abel’s Mission to End Endometriosis

March 11, 2026

Metri Bio’s CEO, Ashley Abel, selected for Forbes 30 Under 30

January 1, 2026

Metri Bio Raises $5M Pre-Seed to Develop Endometriosis Therapeutics

December 2, 2025

Our mission

Metri Bio is working to radically improve the lives of patients suffering from endometriosis and uterine diseases.